Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV

Two-drug regimens (2DRs) are emerging in clinical practice guidelines as treatment option for both naive and treatment-experienced people living with HIV (PLHIV). Objectives: To determine the real-life effectiveness of 2DR with 25 mg RPV plus 50 mg DTG in a single-tablet regimen (RPV/DTG(STR)) and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidalgo-Tenorio, Carmen, Vinuesa, David, García-Vallecillos, Coral, Muñoz-Medina, Leopoldo, Sequera, Sergio, Javier, Rosario, López-Ruz, Miguel Ángel, Sadyrbaeva-Dolgova, Svetlana, Pasquau, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780933/
https://www.ncbi.nlm.nih.gov/pubmed/36560630
http://dx.doi.org/10.3390/v14122626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780933/
https://www.ncbi.nlm.nih.gov/pubmed/36560630
http://dx.doi.org/10.3390/v14122626

Ejemplares similares